Christian Heiss: Paclitaxel Efficacy in Dialysis-Dependent PAD
Christian Heiss, Associate Head of Medical School (Research and Innovation) at the University of Surrey, Professor and NHS Consultant in Interventional Cardiovascular Medicine, shared a post on LinkedIn about a recent article by Chen‐Yu Huang et al., published in JAHA, adding:
“Another interesting paper I came across during weekly journal watch….
This new JAHA paper on paclitaxel efficacy in dialysis-dependent peripheral artery disease is a timely reminder that device performance and treatment benefit need to be understood in the patients we actually treat, not only in lower-risk trial populations.
For PAD, especially in CLTI, the key question is increasingly not simply which device works? — but which device works for which phenotype, with what balance of limb benefit, reintervention risk and survival?”
Title: Paclitaxel Efficacy in Dialysis‐Dependent Peripheral Artery Disease: A National Cohort Analysis
Authors: Chen‐Yu Huang, Hsu‐Ping Wu, Wen‐Jung Chung, Shu‐Kai Hsueh, Donna Shu‐Han Lin, Po‐Chao Hsu, Chun‐Chi Chen, Jen‐Kuang Lee, Chi‐Hung Huang, Hsuan‐Li Huang
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 1, 2026, 09:16Nicolas Gendron: Real-World Data on Danaparoid in Patients with Suspected HIT
-
Sep 1, 2026, 08:24Cristina Chang: The Importance of The New ET Treatments
-
Sep 1, 2026, 07:22Abdul Mannan: ASH 2026 Guidelines – New Treatment Approach for Adult ITP
-
Sep 1, 2026, 07:20Alejandro González Veliz: Silent Atherosclerosis Starts Earlier Than We Think
-
Sep 1, 2026, 07:18Alan Nurden: A New Mechanism Behind Immune Thrombocytopenia
-
Sep 1, 2026, 07:18Susan Shea: New NHLBI Fellowship Supports Thrombinflammation Research
-
Sep 1, 2026, 07:12Sriraman Punniakoti: Pediatric ALL Therapy and Cerebrovascular Thrombosis
-
Sep 1, 2026, 07:04Piotr Czempik: ROTEM in Sepsis-Related Coagulopathy
-
Sep 1, 2026, 07:02Amin Omar Khlifat: Reading the Laboratory Clues to Differentiate Types of Anemia